TCA
BCAT icon

Transcend Capital Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Transcend Capital Advisors’s Portfolio BCAT Stock Details BCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,608
Closed -$642K – 624
2025
Q1 		$642K Buy
44,608
+8,654
+24% +$132K 0.05% 317
2024
Q4 		$545K Sell
35,954
-29,339
-45% -$472K 0.04% 336
2024
Q3 		$1.07M Buy
65,293
+86
+0.1% +$1.41K 0.07% 255
2024
Q2 		$1.07M Buy
65,207
+4,435
+7% +$71.3K 0.08% 243
2024
Q1 		$1.01M Buy
60,772
+5,400
+10% +$83.7K 0.08% 230
2023
Q4 		$828K Buy
55,372
+3,890
+8% +$56.6K 0.07% 237
2023
Q3 		$746K Hold
51,482
– – 0.07% 240
2023
Q2 		$785K Hold
51,482
– – 0.07% 237
2023
Q1 		$779K Buy
51,482
+21,532
+72% +$319K 0.08% 231
2022
Q4 		$415K Sell
29,950
-17,200
-36% -$243K 0.05% 310
2022
Q3 		$642K Sell
47,150
-3,000
-6% -$44.5K 0.07% 245
2022
Q2 		$735K Buy
50,150
+4,000
+9% +$61.8K 0.08% 239
2022
Q1 		$764K Buy
46,150
+12,000
+35% +$211K 0.07% 252
2021
Q4 		$664K Buy
+34,150
New +$664K 0.06% 265

Other funds holding BCAT

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Transcend Capital Advisors's BCAT Position: Q2 2025 in Review

Transcend Capital Advisors sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2025, closing a stake of 44,608 shares — an estimated $642K sold.

Transcend Capital Advisors first reported a position in BCAT in Q4 2021 and held it in 14 quarters. The position peaked at $1.07M in Q3 2024. 91 funds tracked by Wall St. Rank hold BCAT as of Q2 2025.

  • Transcend Capital Advisors reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2025 after selling out during the quarter.
  • Transcend Capital Advisors sold 44,608 BlackRock Capital Allocation Term Trust shares in Q2 2025, an estimated $642K.
  • Transcend Capital Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q4 2021 and held it in 14 quarters.
  • Transcend Capital Advisors's BlackRock Capital Allocation Term Trust position peaked at $1.07M in Q3 2024.
  • 91 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2025.

Based on Transcend Capital Advisors's 13F filing for Q2 2025, filed 1 Aug 2025.